K-RITH and Africa Centre have joined to form a new institute, called the Africa Health Research Institute (AHRI).
The new AHRI website is launching soon! Get our latest news here in the meanwhile.

x

K-Rith

Learn more
about K-RITH
READ MORE

K-RITH conducts cutting-edge scientific research on TB and HIV and aims to translate the findings into new tools to control these diseases.

Research

New study shows ‘treat all’ not a panacea for early ART uptake

Eliminating CD4 thresholds is unlikely to lead to a critical mass of people living with HIV starting antiretroviral treatment (ART) in South Africa. A new study by Africa Health Research Institute (AHRI) researchers and Boston University colleagues, published in PLOS ONE in June, shows that ART uptake in rural KwaZulu-Natal (KZN) among treatment-eligible patients is

read more

Research

Africa Health Research Institute celebrates two PhD graduates

Two Africa Health Research Institute (AHRI) students have graduated with their PhDs from the University of Witwatersrand. Dr Ntombizodumo (Dumo) Mkwanazi and Dr Natsayi Chimbindi were part of the July 5th Faculty of Health Sciences graduation at the university. Dr Ntombizodumo Mkwanazi’s research focussed on the experiences of women enrolled in AHRI’s Amagugu maternal HIV-disclosure

read more

Our Scientists

Adrie Steyn

STEYN LAB

The main goal of the Steyn Lab’s research is to understand the mechanisms whereby Mycobacterium tuberculosis persist for decades without causing disease, to then suddenly explode.

READ MORE

Al Leslie

LESLIE LAB

The Leslie Lab investigates the innate immune response to HIV and TB and how novel aspects of this response may potentially be exploited to improve patient outcomes.

READ MORE

Alex Sigal

SIGAL LAB

The aim of the Sigal Lab is to understand HIV and TB transmission between cells and how it affects the persistence of infection, sensitivity to drugs, rate of the infection cycle and, for HIV, the formation of a quasispecies.

READ MORE

Alexander Pym

PYM LAB

The Pym Lab focusses on understanding how the TB bacterium is able to tolerate or resist antibiotics.

READ MORE

Thumbi Ndung'u

NDUNG'U LAB

The goal of the Ndung’u laboratory is to understand immune mechanisms against HIV and tuberculosis, and pathogen evasion of immune responses as a pathway to vaccine development.

READ MORE
NEWS | Research

Africa Health Research Institute celebrates two PhD graduates

Two Africa Health Research Institute (AHRI) students have graduated with their PhDs from the University of Witwatersrand. Dr Ntombizodumo (Dumo) Mkwanazi and Dr Natsayi Chimbindi were part of the July 5th Faculty of Health Sciences graduation at the university. Dr Ntombizodumo Mkwanazi’s research focussed on the experiences of women enrolled in AHRI’s Amagugu maternal HIV-disclosure

READ MORE
NEWS | Research

New study shows ‘treat all’ not a panacea for early ART uptake

Eliminating CD4 thresholds is unlikely to lead to a critical mass of people living with HIV starting antiretroviral treatment (ART) in South Africa. A new study by Africa Health Research Institute (AHRI) researchers and Boston University colleagues, published in PLOS ONE in June, shows that ART uptake in rural KwaZulu-Natal (KZN) among treatment-eligible patients is

READ MORE
NEWS | Research

Prof Deenan Pillay on The Truth About HIV

“Defeating this awful HIV epidemic requires an understanding of society, as well as individuals, as well as medicine. And without an understanding of all of those, we will never defeat it,” says Director of Africa Health Research Institute, Professor Deenan Pillay. On the 25 May 2017, BBC One aired The Truth About HIV; a documentary

READ MORE

Search below for content